Treatment of advanced colorectal cancer with high-dose intensity folinic acid and 5-fluorouracil plus supportive care
- 30 November 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (12), 2105-2108
- https://doi.org/10.1016/0959-8049(95)00488-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Systemic treatment of colorectal cancerEuropean Journal Of Cancer, 1994
- Systemic Infusion Versus Bolus Chemotherapy with 5-Fluorouracil in Measurable Metastatic Colorectal CancerAmerican Journal of Clinical Oncology, 1992
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.Journal of Clinical Oncology, 1989
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancerCancer, 1989
- High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- PALLIATIVE CHEMOTHERAPY FOR RELIEF OF SUBOCCLUSIVE SYMPTOMSThe Lancet, 1987
- Prognostic factors of advanced colorectal cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1986